Press Releases

Press Releases

Search by keywords:

186 Press Releases found

IBM Watson Hard At Work: New Breakthroughs Transform Quality Care for Patients

IBM, WellPoint, Inc., and Memorial Sloan Kettering Cancer Center today unveiled the first commercially developed Watson-based cognitive computing breakthroughs. These innovations stand alone to help transform the quality and speed of care delivered to patients through individualized, evidence-based medicine.

  • Friday, February 8, 2013

New Position Created to Streamline, Accelerate, and Expand Clinical Research at Memorial Sloan Kettering

Memorial Sloan Kettering Cancer Center has announced the appointment of medical oncologist Paul Sabbatini to the new position of Deputy Physician-in-Chief for Clinical Research.

  • Thursday, January 17, 2013

David M. Rubenstein Gives $10 Million to Launch Pancreatic Cancer Research Center at Memorial Sloan Kettering

A new pancreatic cancer research center has been created at Memorial Sloan Kettering Cancer Center (MSKCC). The ambitious initiative was established with an initial commitment of $10 million from MSKCC Board member David M. Rubenstein.

  • Friday, December 7, 2012

Medication Before and After Treatment Improves Overall Sexual Function in Men with Prostate Cancer

Prostate cancer patients who are prescribed oral erectile medication before and after radiation therapy have improved sexual function, according to a research team at Memorial Sloan Kettering Cancer Center.

  • Monday, October 29, 2012

Memorial Sloan Kettering Cancer Center Announces Appointment of New Physician-in-Chief

Internationally recognized physician-scientist José Baselga has been named Physician-in-Chief of Memorial Hospital. He joins Memorial Sloan Kettering from Massachusetts General Hospital.

  • Wednesday, September 5, 2012

Childhood Cancer Treatment Found to Pose Similar Risk for Breast Cancer as BRCA Mutations

New data reveals that women treated with radiation to the chest for childhood cancer have a high risk of developing breast cancer similar to that of women with BRCA1/2 mutations. The study, led by Memorial Sloan Kettering Cancer Center biostatistician Chaya Moskowitz, PhD, was presented today at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.

  • Monday, June 4, 2012

Testing for Mutations Identified in Squamous Cell Lung Cancer Tumors Helps Personalize Treatment

Researchers from Memorial Sloan Kettering Cancer Center have begun testing for three new genetic targets and found that together they occur in approximately 50 percent of patients with squamous cell carcinomas of the lung, which affects 40,000 Americans each year. Initial findings of the research will be presented on June 4 at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.

  • Wednesday, May 16, 2012

Memorial Sloan Kettering Commack Offers Free Mammograms to Eligible Women on Long Island

Women on Long Island who don’t have insurance or who are underinsured may be able to take advantage of free mammograms at Memorial Sloan Kettering Cancer Center Commack.

  • Tuesday, May 8, 2012

Memorial Sloan Kettering's Website Nominated for Webby Award

Memorial Sloan Kettering Cancer Center’s website has been nominated for The Webby Award, the most prestigious international award honoring excellence on the Internet. Selected from among nearly 10,000 total entries, the Center’s website is one of five nominated in the Health category.

  • Thursday, April 12, 2012

Antibody Therapy Prevents Gastrointestinal Damage following Radiation Exposure in Mice

A new study offers the first evidence of a drug capable of preventing lethal damage to the gastrointestinal (GI) tract caused by exposure to high levels of ionizing radiation, such as those occurring during a nuclear incident.

  • Wednesday, April 4, 2012